Research at Berlin-Buch
The Berlin-Buch Campus is a unique site for medical research and development in Germany. The Max Delbrück Center for Molecular Medicine (MDC), founded in 1992 as a model for clinical research from three institutes of the GDR Academy of Sciences, was the initial driving force for the development of the campus into a research and biotechnology site of supraregional significance. Since 2000, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has played a major role in this development.
Today, on the 32-hectare site which can look back on a long scientific tradition, institutes for basic medical research, research clinics and biotechnology companies are located in close proximity to each other. Buch's researchers, doctors and entrepreneurs are collaborating in the development of new treatments and diagnostic procedures for cancer, cardiovascular and nervous system diseases.
A modern Congress Center with integrated laboratories on the campus offers multiple opportunities for scientific interaction.
News research
ERC Advanced Grants awarded to two Berlin researchers
Uwe Ohler and Gaetano Gargiulo have been awarded prestigious ERC Advanced Grants. With funding of €2.5 million each, they will spend the next five years investigating how protein synthesis is regulate...
more ...Berlin honors outstanding deep-tech companies—including MyoPax
This year, for the first time, a Deep Tech Award was presented in the Bio & Health Tech category. The winner is MyoPax, a spin-off of the Max Delbrück Center and Charité.
more ...First Joint Career Day Brings Science and Industry Together
The Max Delbrück Center’s Career Day, held in cooperation with the operator of the Berlin-Buch Campus, offered young researchers insights into the working world of startups and biotech companies
more ...Events Campus
27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)
Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...
more ...22.09.2026, 09:00
GMP Biotech Summer School
Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.
more ...
